SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-383690
Filing Date
2017-12-29
Accepted
2017-12-29 17:04:35
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d497481ds3.htm S-3 337803
2 EX-4.6 d497481dex46.htm EX-4.6 307990
3 EX-4.8 d497481dex48.htm EX-4.8 97263
4 EX-4.9 d497481dex49.htm EX-4.9 101865
5 EX-4.10 d497481dex410.htm EX-4.10 87378
6 EX-5.1 d497481dex51.htm EX-5.1 24044
7 EX-23.1 d497481dex231.htm EX-23.1 1603
8 GRAPHIC g497481g1222082753905.jpg GRAPHIC 2528
9 GRAPHIC g497481g73a92.jpg GRAPHIC 25606
  Complete submission text file 0001193125-17-383690.txt   998147
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-222372 | Film No.: 171282577
SIC: 2834 Pharmaceutical Preparations